Sangamo Therapeutics
SGMO
#8250
Rank
โ‚ฌ0.17 B
Marketcap
0,80ย โ‚ฌ
Share price
1.46%
Change (1 day)
38.83%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -โ‚ฌ0.13 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ52.29 Million. In 2023 the company made an earning of -โ‚ฌ0.12 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.13 Billion11.81%
2023 -โ‚ฌ0.12 Billion-40.88%
2022 -โ‚ฌ0.19 Billion9.79%
2021 -โ‚ฌ0.18 Billion41.52%
2020 -โ‚ฌ0.13 Billion23.17%
2019 -โ‚ฌ97.66 Million36.33%
2018 -โ‚ฌ71.64 Million36.89%
2017 -โ‚ฌ52.34 Million-22.32%
2016 -โ‚ฌ67.38 Million54.86%
2015 -โ‚ฌ43.51 Million75.62%
2014 -โ‚ฌ24.78 Million0.13%
2013 -โ‚ฌ24.75 Million
2011 -โ‚ฌ33.26 Million43.66%
2010 -โ‚ฌ23.16 Million28.52%
2009 -โ‚ฌ18.02 Million-23.55%
2008 -โ‚ฌ23.57 Million2.45%
2007 -โ‚ฌ23 Million19.5%
2006 -โ‚ฌ19.25 Million50.78%
2005 -โ‚ฌ12.77 Million75%
2004 -โ‚ฌ7.3 Million-33.25%
2003 -โ‚ฌ10.93 Million-62.27%
2002 -โ‚ฌ28.97 Million102.82%
2001 -โ‚ฌ14.29 Million23.21%
2000 -โ‚ฌ11.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ0.64 B-614.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.22 Billion 75.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.27 B-3,533.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.76 B-1,520.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.48 B-1,292.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.19 B-13,094.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.50 B-503.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.69 B-15,900.06%๐Ÿ‡บ๐Ÿ‡ธ USA